Riskpilot← Back to searchSign inGet full accessMästersmedjan AB
ABActiveOrg 5591318307NyköpingActivities of holding companies · NACE 6421Est. 20170 employees
Revenue 2024
SEK 630K
-60% vs 2023
EBITDA margin
-1539.7%
-1556% vs 2023
Equity ratio
97.2%
Financial strength
Net profit 2024
SEK -4,7M
-6% vs 2023
| Revenue | SEK 630K | -60% |
| EBITDA | SEK -9,7M | -1556% |
| Net profit | SEK -4,7M | -6% |
| Total assets | SEK 59,4M | -6% |
| Equity | SEK 57,7M | -7% |
| Employees | 0 | — |
Legal name
Mästersmedjan AB
Org number
5591318307
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
1 november 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska äga och förvalta värdepapper, bedriva digital forskning och utveckling, bedriva idrotts och hälsofrämjande aktiviteter, samt därmed förenlig verksamhet.
Address
Nyköping
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 048 | 1 890 | 1 845 | 1 568 | 630 |
| Staff expenses | — | — | — | −895 | −789 |
| EBITDA | 305 | −608 | −56 | −586 | −9 700 |
| Depreciation & amort. | −13 | −5 | −0 | −3 991 | — |
| EBIT | 292 | −613 | −56 | −4 577 | −9 700 |
| Net financials | 61 588 | 5 498 | 118 | 135 | 4 999 |
| Profit before tax | 61 880 | 4 886 | 63 | −4 442 | −4 701 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | 61 880 | 4 886 | 63 | −4 442 | −4 701 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 62 797 | 67 375 | 67 550 | 63 412 | 59 387 |
| Equity | 61 838 | 66 724 | 66 786 | 62 344 | 57 748 |
| Long-term debt | 0 | 0 | 0 | — | 898 |
| Short-term debt | 959 | 651 | 763 | 1 068 | 741 |
| Total debt | 959 | 651 | 763 | 1 068 | 1 639 |
EBITDA margin
-1539.7%
This company
15.8%
Market median
-9845% vs market
20202024
Equity ratio
97.2%
This company
38.2%
Market median
+154% vs market
20202024
Return on equity
-8.1%
This company
18.4%
Market median
-144% vs market
20202024
Net profit margin
-746.3%
This company
8.1%
Market median
-9314% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
AT Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mästersmedjan AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anneli Teresia Wirf | Deputy Chief Executive Officer | 0 companies |
| Jens Viktor Wirf | Deputy Board Member | 0 companies |
| Johan Peter Wirf | Board of Directors | 0 companies |